雷奥病毒瘤溶解和这个独特的瘤病毒免疫疗法的下一个前沿
Negar Sharifi1, Amir Emamie2, Nastaran Rafiee3
1Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Seminars in immunology
|October 1, 2025
概括
雷奥病毒是一种有前途的瘤性病毒,通过向癌细胞并刺激免疫系统,在癌症免疫治疗中显示出潜力. 交付和工程方面的进步提高了未来癌症治疗的安全性和有效性.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 雷奥病毒是一种经过临床研究的瘤性病毒,具有强大的安全性.
- 它在恶性细胞中优先复制,对正常组织的毒性最小.
- 雷奥病毒已经表现出免疫刺激性质,使其对癌症免疫治疗具有吸引力.
研究的目的:
- 审查基于reovirus的病毒疗法的最新进展.
- 探索新兴的策略,以提高reovirus的治疗潜力.
- 突出重复病毒作为下一代免疫治疗平台.
主要方法:
- 临床试验和科学文献关于reovirus的综述.
- 分析reovirus的作用机制,包括直接瘤溶解和免疫激活.
- 对新型传递系统和基因工程方法的评估.
主要成果:
- 雷奥病毒表现出超出直接杀死瘤细胞的潜力,包括瘤微环境调节和免疫系统激活.
- 雷奥病毒与化学疗法,放射治疗和免疫检查点抑制剂等常规癌症疗法产生协同作用.
- 传递方法 (口服,纳米粒子,干细胞介导) 和基因工程方面的进步提高了reovirus的安全性,向性和有效性.
结论:
- 雷奥病毒是癌症免疫治疗的有希望的候选者,因为它具有瘤性活性,安全性和免疫刺激作用.
- 新兴的策略正在扩大reovirus的治疗应用,并提高其临床效用.
- 雷奥病毒代表了开发下一代癌症免疫疗法的多功能平台.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


